scholarly journals U1 snRNA promotes the selection of nearby 5' splice sites by U6 snRNA in mammalian cells.

1996 ◽  
Vol 10 (3) ◽  
pp. 338-350 ◽  
Author(s):  
D Y Hwang ◽  
J B Cohen
1998 ◽  
Vol 18 (12) ◽  
pp. 7510-7520 ◽  
Author(s):  
Laura O’Mullane ◽  
Ian C. Eperon

ABSTRACT Efficient splicing of the 5′-most intron of pre-mRNA requires a 5′ m7G(5′)ppp(5′)N cap, which has been implicated in U1 snRNP binding to 5′ splice sites. We demonstrate that the cap alters the kinetic profile of U1 snRNP binding, but its major effect is on U6 snRNA binding. With two alternative wild-type splice sites in an adenovirus pre-mRNA, the cap selectively alters U1 snRNA binding at the site to which cap-independent U1 snRNP binding is stronger and that is used predominantly in splicing; with two consensus sites, the cap acts on both, even though one is substantially preferred for splicing. However, the most striking quantitative effect of the 5′ cap is neither on U1 snRNP binding nor on the assembly of large complexes but on the replacement of U1 snRNP by U6 snRNA at the 5′ splice site. Inhibition of splicing by a cap analogue is correlated with the loss of U6 interactions at the 5′ splice site and not with any loss of U1 snRNP binding.


2005 ◽  
Vol 333 (1) ◽  
pp. 64-69 ◽  
Author(s):  
Jianning Bi ◽  
Huiyu Xia ◽  
Fei Li ◽  
Xuegong Zhang ◽  
Yanda Li

The Analyst ◽  
2017 ◽  
Vol 142 (21) ◽  
pp. 4030-4038 ◽  
Author(s):  
Kazuki Hirose ◽  
Maho Tsuchida ◽  
Hinako Asakura ◽  
Koji Wakui ◽  
Keitaro Yoshimoto ◽  
...  

A single-round DNA aptamer selection for mammalian cells was successfully achieved for the first time using a capillary electrophoresis (CE)-based methodology.


1993 ◽  
Vol 13 (5) ◽  
pp. 2666-2676 ◽  
Author(s):  
J B Cohen ◽  
S D Broz ◽  
A D Levinson

Pre-mRNA 5' splice site activity depends, at least in part, on base complementarity to U1 small nuclear RNA. In transient coexpression assays, defective 5' splice sites can regain activity in the presence of U1 carrying compensatory changes, but it is unclear whether such mutant U1 RNAs can be permanently expressed in mammalian cells. We have explored this issue to determine whether U1 small nuclear RNAs with altered specificity may be of value to rescue targeted mutant genes or alter pre-mRNA processing profiles. This effort was initiated following our observation that U1 with specificity for a splice site associated with an alternative H-ras exon substantially reduced the synthesis of the potentially oncogenic p21ras protein in transient assays. We describe the development of a mammalian complementation system that selects for removal of a splicing-defective intron placed within a drug resistance gene. Complementation was observed in proportion to the degree of complementarity between transfected mutant U1 genes and different defective splice sites, and all cells selected in this manner were found to express mutant U1 RNA. In addition, these cells showed specific activation of defective splice sites presented by an unlinked reporter gene. We discuss the prospects of this approach to permanently alter the expression of targeted genes in mammalian cells.


Author(s):  
Richard Mortensen ◽  
Jonathan D. Chesnut ◽  
James P. Hoeffler ◽  
Robert E. Kingston
Keyword(s):  

2003 ◽  
Vol 77 (16) ◽  
pp. 8695-8701 ◽  
Author(s):  
Nathan J. Kelly ◽  
Matthew T. Palmer ◽  
Casey D. Morrow

ABSTRACT Initiation of retrovirus reverse transcription requires the selection of a tRNA primer from the intracellular milieu. To investigate the features of primer selection, a human immunodeficiency virus type 1 (HIV-1) and a murine leukemia virus (MuLV) were created that require yeast tRNAPhe to be supplied in trans for infectivity. Wild-type yeast tRNAPhe expressed in mammalian cells was transported to the cytoplasm and aminoacylated. In contrast, tRNAPhe without the D loop (tRNAPheD−) was retained within the nucleus and did not complement infectivity of either HIV-1 or MuLV; however, infectivity was restored when tRNAPheD− was directly transfected into the cytoplasm of cells. A tRNAPhe mutant (tRNAPheUUA) that did not have the capacity to be aminoacylated was transported to the cytoplasm and did complement infectivity of both HIV-1 and MuLV, albeit at a level less than that with wild-type tRNAPhe. Collectively, our results demonstrate that the tRNA primer captured by HIV-1 and MuLV occurs after nuclear export of tRNA and supports a model in which primer selection for retroviruses is coordinated with tRNA biogenesis at the intracellular site of protein synthesis.


1993 ◽  
Vol 12 (9) ◽  
pp. 3607-3617 ◽  
Author(s):  
I.C. Eperon ◽  
D.C. Ireland ◽  
R.A. Smith ◽  
A. Mayeda ◽  
A.R. Krainer
Keyword(s):  

2004 ◽  
Vol 10 (1) ◽  
pp. 191-199 ◽  
Author(s):  
Michela Alessandra Denti ◽  
Alessandro Rosa ◽  
Olga Sthandier ◽  
Fernanda Gabriella De Angelis ◽  
Irene Bozzoni
Keyword(s):  

2002 ◽  
Vol 12 (5) ◽  
pp. 341-352 ◽  
Author(s):  
Masayuki Sano ◽  
Tomoko Kuwabara ◽  
Masaki Warashina ◽  
Akiyoshi Fukamizu ◽  
Kazunari Taira

1988 ◽  
Vol 16 (15) ◽  
pp. 7383-7395 ◽  
Author(s):  
Manfred W. Müller ◽  
Rudolf J. Schweyen ◽  
Carlo Schmelzer

Sign in / Sign up

Export Citation Format

Share Document